Latest Impairment News

Page 53 of 54
Argenica Therapeutics reports compelling preclinical evidence that its lead candidate ARG-007 significantly reduces brain cell damage and inflammation in moderate traumatic brain injury models, marking a promising step toward new TBI treatments.
Ada Torres
Ada Torres
4 Feb 2025
Strata Minerals Limited has identified four significant drill targets at its Penny South Gold Project in WA and is set to commence its maiden drilling program in February 2025, signaling a major step forward in its exploration strategy.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Jervois Global Limited has entered a pivotal recapitalization agreement with Millstreet Capital Management, involving a US$145 million equity injection and a pre-packaged Chapter 11 bankruptcy process. The company aims to strengthen its balance sheet and continue operations uninterrupted while preparing for a strategic restart of its nickel-cobalt refinery in Brazil.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Vintage Energy has launched a $2.1 million entitlement offer to fund a targeted production uplift program at its Odin and Vali gas fields, aiming to significantly increase gas output and cash flow in the near term.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Frontier Digital Ventures posts a mixed fourth quarter with overall revenue growth but EBITDA pressures, while advancing a strategic review focused on unlocking shareholder value.
Victor Sage
Victor Sage
31 Jan 2025
Alterity Therapeutics has reported positive Phase 2 results for ATH434, showing significant slowing of Multiple System Atrophy progression and a favorable safety profile. The trial demonstrated clinical benefits alongside reductions in brain iron accumulation, a key disease driver.
Ada Torres
Ada Torres
30 Jan 2025
Mineral Commodities Ltd reported a steep net loss of USD 65.1 million for H1 2024, driven by operational disruptions at its Tormin mine and strategic moves including the sale of its Skaland Graphite Project.
Maxwell Dee
Maxwell Dee
30 Jan 2025
IGO's December quarter report reveals robust performance at Greenbushes lithium mine but significant setbacks at Kwinana and Nova, culminating in a $79 million EBITDA loss and a strategic halt on Kwinana’s Plant 2.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Credit Corp Group reported steady H1 FY25 results with operational improvements and confirmed full-year guidance, driven by growth in US debt buying and stable Australian/New Zealand lending.
Claire Turing
Claire Turing
30 Jan 2025
Credit Corp Group Limited has reported a remarkable turnaround for the half-year ended 31 December 2024, posting a 464% increase in profit after tax to $44.1 million and a 45% rise in revenue to $271.5 million. The company also declared a fully franked interim dividend of 32 cents per share, signalling confidence in ongoing growth.
Claire Turing
Claire Turing
30 Jan 2025
Acusensus has secured major contract expansions across Australia and New Zealand, driving a 15.8% revenue increase in Q2 FY25 and bolstering its cash reserves to $30.3 million. The company’s strategic international push and innovative enforcement technologies position it for sustained growth.
Sophie Babbage
Sophie Babbage
30 Jan 2025
Southern Cross Gold Consolidated Ltd. reported a significantly reduced net loss of $2.41 million for Q2 2024, down from $43.69 million a year earlier, as it sharpens focus on its Australian gold projects following a major corporate restructuring.
Maxwell Dee
Maxwell Dee
29 Jan 2025